// App-Quantinova.ai

84 : Application of active surveillance threshold to series of samples submitted for commercial testing.

Researchers

Presenter

  • Peter T. Scardino

Principal Investigators

  • Jack M. Cuzick

  • Steve Stone

  • Brent Evans

  • Matthew R Jorgensen

  • James Andrew Eastham

  • Thomas E. Keane

  • John W. Davis

  • Daniel W. Lin

  • Judd W. Moul

  • Michael K. Brawer

  • E. David Crawford

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Wolfson Institute of Preventive Medicine, London, United Kingdom

  • Myriad Genetics, Inc., Salt Lake City, UT

  • Myriad Genetics, Inc., Salt Lake City, UT

  • Medcl Univ of South Carolina, Charleston, SC

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of Washington, Seattle, WA

  • Duke Cancer Institute, Durham, NC

  • University of Colorado Cancer Center, Aurora, CO

Locations

  • United States

  • United Kingdom

Companies

  • Myriad Genetics, Inc

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved